SNDL Inc.
SNDL- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001766600
No open-market purchases or sales by SNDL Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 108
- 13F valueReported value at the end of Q2 2026
- $66.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SNDL, Q2 2026
No superinvestor reported holding SNDL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by SNDL Inc. insiders from Form 4, newest first.
No open-market purchases or sales by SNDL Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in SNDL Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 10,214,013 | $13.8M | 0.00% | −1,197,108−10.5% | Reduced |
| Cannell Capital LLC | 8,639,381 | $11.7M | 8.14% | −121,774−1.4% | Reduced |
| Toroso Investments, LLC | 5,334,370 | $7.20M | 0.02% | −176,305−3.2% | Reduced |
| Arrowstreet Capital, Limited Partnership | 2,357,401 | $3.18M | 0.00% | −639,022−21.3% | Reduced |
| Citadel Advisors LLC | 2,165,081 | $2.92M | 0.00% | +286,969+15.3% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 2,113,976 | $2.85M | 0.00% | −125,388−5.6% | Reduced |
| Goldman Sachs Group Inc | 1,970,467 | $2.66M | 0.00% | +788,392+66.7% | Added |
| Susquehanna International Group, LLP | 1,913,418 | $2.58M | 0.00% | +351,097+22.5% | Added |
| Ewing Morris & Co. Investment Partners Ltd. | 1,481,222 | $1.99M | 1.04% | +180,000+13.8% | Added |
| JPMorgan Chase & Co | 1,262,553 | $1.74M | 0.00% | −135,767−9.7% | Reduced |